Sonia Capellero

HER2-positive breast cancer cells resistant to trastuzumab and lapatinib lose reliance upon HER2 and are sensitive to the multitargeted kinase inhibitor sorafenib

Giorgio Valabrega, Sonia Capellero, Giuliana Cavalloni et al. · Breast Cancer Research and Treatment · 2010 · 49 citations

Medicine, Oncology, Pharmacology +16

CSPG4-Specific CAR.CIK Lymphocytes as a Novel Therapy for the Treatment of Multiple Soft-Tissue Sarcoma Histotypes

Valeria Leuci, Chiara Donini, Giovanni Grignani et al. · Clinical Cancer Research · 2020 · 44 citations · Full text

Life Sciences, Immunology, Oncology +15

Ovarian Cancer Cells in Ascites Form Aggregates That Display a Hybrid Epithelial-Mesenchymal Phenotype and Allows Survival and Proliferation of Metastasizing Cells

Sonia Capellero, Jessica Erriquez, Chiara Battistini et al. · International Journal of Molecular Sciences · 2022 · 41 citations · Full text

Medicine, Cell Biology, Oncology +17

Transient proteasome inhibition as a strategy to enhance lentiviral transduction of hematopoietic CD34+ cells and T lymphocytes: Implications for the use of low viral doses and large-size vectors

Valeria Leuci, Giulia Mesiano, Loretta Gammaitoni et al. · Journal of Biotechnology · 2011 · 13 citations

Life Sciences, Hematology, Immunology +10

PIK3R1W624R Is an Actionable Mutation in High Grade Serous Ovarian Carcinoma

Concetta D’Ambrosio, Jessica Erriquez, Maddalena Arigoni et al. · Cells · 2020 · 13 citations · Full text

Medicine, Cancer Biology, Oncology +17